Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
anticoagulant, complications of
anticoagulant, self-monitoring
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation clinic
artificial intelligence
atrial fibrillation
atrial fibrillation, risk stratification
cerebrovascular accident
cerebrovascular accident, prevention of
cerebrovascular accident, severity
CHADS-VaSC score
compliance
complications
computers, medicine and
controversies in neurology
coumarin
dabigatran
dabigatran, dose
efficacy
factor Xa inhibitor
HAS-BLED score
heart valve, prosthetic
hemorrhagic diathesis
INR value, time in range
INR values
intracerebral hemorrhage
laboratory values, normal
medical app
microhemorrhage, intracerebral
mortality
non-vitamin K antagonist oral anticoagulants
patient information and support
platelet inhibiting drugs
point of care
practice guidelines
prevention of neurologic disorders
quality of life
RELY trial
review article
safety
self monitoring
smartphone
treatment of neurologic disorder
Showing articles 600 to 650 of 1135 << Previous Next >>

Oral Anticoagulation for Cerebral Ischemic of Arterial Origin
Neurol 57:1993-1999, Torn,M.,et al, 2001

Treatment of Acute Basilar Artery Thrombosis With a Combination of Systemic Alteplase and Tirofiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Inhibitor: Report of Four Cases
Radiology 221:795-801, Junghans,U.,et al, 2001

Magnetic Resonance Imaging of Cerebral Microbleeds
Current Opinion in Neurology 13:69-73, Roob,G.&Fazekas,F., 2000

North Carolina Stroke Prevention and Treatment Facilities Survey
Stroke 31:66-70, Goldstein,L.B.,et al, 2000

Stroke Prevention
Neurol Clin 18:321-341, Wein,T.H. &Bornstein,N.M., 2000

AGGRENOX: A Combination of Antiplatelet Drugs for Stroke Prevention
The Medical Letter 442:11-12, , 2000

Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000

Intraspinal Hemorrhage Complicating Oral Anticoagulant Therapy, An Unusual Case of Cervical Hematomyelia and a Review of the Literature
Arch Int Med 160:237-240, Pullarkat,V.A.,et al, 2000

Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events
ArchNeurol 57:326-332,306, Hart,R.G.,et al, 2000

Early Lacunar Strokes Complicating Polyarteritis Nodosa
Neurol 54:883-889, Reichhart,M.D.,et al, 2000

Cerebral Sinus Thrombosis Diagnosed by MRI and MR Venography in Cancer Patients
Neurol 54:1222-1226, Raizer,J.J.&DeAngelis,L.M., 2000

Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000

Aspirin-Associated Intracerebral Hemorrhage
Neurol 54:2298-2301, Wong,K.S.,et al, 2000

Update on Antiplatelet Therapy for Stroke Prevention
Arch Int Med 160:1579-1582, Sacco,R.L.& Elkind,M.S., 2000

Anticoagulation for Chronic Atrial Fibrillation
JAMA 283:2901-2903, Stern,S.,et al, 2000

Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
NEJM 342:1773-1777,1824, Bennett,C.L.,et al, 2000

Indications for Early Aspirin Use in Acute Ischemic Stroke
Stroke 31:1240-1249, Chen,Z.,et al, 2000

Stroke Prevention
Neurol 54:1899-1906, Holloway,R.G.,et al, 2000

Suicidal Ideation Among Outpatients at General Neurology Clinics: Prospective Study
BMJ 320:1311-1312, Carson,A.J.,et al, 2000

Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000

Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000

Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000

Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000

Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in patients at High Risk of Vascular Disease?
Stroke 31:1779-1784, Hankey,G.J. et al, 2000

Low-Molecular-Weight heparins and Heparinoids in Acute ischemic Stroke
Stroke 31:1770-1778, Bath,P.M.W. et al, 2000

Symptomatic Intracranial Atherosclerosis
Neurol 55:490-497, 465, Thijs,V.N. & Albers,G.W., 2000

Management of Intracranial Bleeding Associated with Anticoagulation: Balancing the Risk of Further Bleeding Against Thromboembolism From Prosthetic Heart Valves
JNNP 69:396-398, Crawley,F. et al, 2000

Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000

Primary Stenting for High-Grade Basilar Artery Stenosis
AJNR 21:1744-1749, Phatouros,C.C.,et al, 2000

Warfarin-Associated Hemorrhage and Cerebral Amyloid Angiopathy
Neurol 55:947-951, Rosand,J.,et al, 2000

Cost-Effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Arch Int Med 160:2773-2778, Sarasin,F.P.,et al, 2000

Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000

Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000

Safety of Discontinuation of Anticoagulation in Patients with Intracranial Hemorrhage at High Thromboembolic Risk
Arch Neurol 57:1710-1713,1682, Phan,T.G.,et al, 2000

Predictive Testing for Huntington's Disease: the Calm After the Storm
Lancet 356:1944-1945, Hayden,M.R., 2000

Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke
Stroke 31:3067-3078, Bushnell,C.D. & Goldstein,L.B., 2000

Subarachnoid Haemorrhage Treated with Anticoagulants
Lancet 356:1818, Ciccone,A.,et al, 2000

Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000

Special Report: Complications of Lumbar Puncture and Their Prevention with Atraumatic Lumbar Puncture Needles
Medscape:e7-e11, Evans,R.W., 2000

Cerebral Venous Thrombosis
The Neurologist 5:326-349, Biousse,V.&Bousser,M., 1999

Frequency of Major Complications of Aspirin,Warfarin,and Intravenous Heparin for Secondary Stroke Prevention,A Population-Based Study
Ann Int Med 130:14-22, Petty,G.W.,et al, 1999

Cerebral Venous Thrombosis,Combined Intrathrombus rtPA and Intravenous Heparin
Stroke 30:489-494,481, Frey,J.L.,et al, 1999

Cerebral Venous Thrombosis,Nothing,Heparin,or Local Thrombolysis?
Stroke 30:481-483, Bousser,M-G, 1999

Randomized,Placebo-Controlled Trial of Anticoagulant Treatment with Low-Molecular-Weight Heparin for Cerebral Sinus Thrombosis
Stroke 30:484-488,481, de Bruijn,S.F.T.M.,et al, 1999

Oral Anticoagulation in Patients with Atrial Fibrillation:Adherence with Guidelines in an Elderly Cohort
Am J Med 106:165-171, White,R.H.,et al, 1999

Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999

Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone?
JNNP 66:557-559, Algra,A.,et al, 1999

Choosing Antithrombotic Therapy for Elderly Patients with Atrial Fibrillation Who are at Risk for Falls
Arch Int Med 159:677-685, Man-Son-Hing,M.,et al, 1999

Preventing Stroke in Patients with Atrial Fibrillation
JAMA 281:1830-1835, Ezekowitz,M.D.&Levine,J.A., 1999

Antiplatelet Therapy in Acute Cerebral Ischemia
Stroke 30:887-893, Bednar,M.M.&Gross,C.E., 1999



Showing articles 600 to 650 of 1135 << Previous Next >>